XTL-6865

XTL-6865 Uses, Dosage, Side Effects, Food Interaction and all others data.

XTL-6865 is a combination of two fully human monoclonal antibodies (Ab68 and Ab65) against the hepatitis C virus E2 envelope protein. It is being developed to prevent HCV re-infection following a liver transplant and for the treatment of chronic HCV disease.

Table Of contents

• XTL-6865
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	XTL-6865
Generic	XTL-6865
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in hepatitis (viral, C).

How XTL-6865 works

XTL-6865 is a dual-antibody (Ab68 and Ab65) therapy directed against the highly mutagenic hepatitis C E2 envelope protein and intended therefore to inhibit viral entry into host cells.

Innovators Monograph

You find simplified version here XTL-6865